TEVA PHARMACEUTICAL INDUSTRIES LIMITED Finite-Lived Intangible Asset, Expected Amortization, Year One
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $484.00 million as of 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-02-03
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $484.00M.
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $491.00M.
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $503.00M.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $597.00M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-12-31 | $484.00M 10-K · filed 2026-02-03 |
| 2024-12-31 | $491.00M 10-K · filed 2025-02-05 |
| 2023-12-31 | $503.00M 10-K · filed 2024-02-12 |
| 2022-12-31 | $597.00M 10-K · filed 2023-02-10 |
| 2021-12-31 | $689.00M 10-K · filed 2022-02-09 |
| 2020-12-31 | $812.00M 10-K · filed 2021-02-10 |
| 2019-12-31 | $1.02B 10-K · filed 2020-02-21 |
| 2018-12-31 | $1.03B 10-K · filed 2019-02-19 |